perifosine has been researched along with bay 11-7082 in 1 studies
Studies (perifosine) | Trials (perifosine) | Recent Studies (post-2010) (perifosine) | Studies (bay 11-7082) | Trials (bay 11-7082) | Recent Studies (post-2010) (bay 11-7082) |
---|---|---|---|---|---|
245 | 31 | 140 | 570 | 1 | 383 |
Protein | Taxonomy | perifosine (IC50) | bay 11-7082 (IC50) |
---|---|---|---|
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.82 | |
Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 2 | |
Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | 2 | |
Transcription factor p65 | Homo sapiens (human) | 2.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CY; Cheng, YW; Hsu, NY; Lee, H; Lee, MC; Wang, YC; Wu, DW; Wu, JY; Wu, TC | 1 |
1 other study(ies) available for perifosine and bay 11-7082
Article | Year |
---|---|
FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction.
Topics: Acid Anhydride Hydrolases; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Resistance, Neoplasm; Female; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoplasm Proteins; Neoplasm Transplantation; Nitriles; Phosphorylcholine; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; RNA Interference; RNA, Small Interfering; Snail Family Transcription Factors; Sulfones; Transcription Factor RelA; Transcription Factors; Transplantation, Heterologous; Treatment Outcome | 2015 |